Transcription_NN
factor_NN
jun-B_NN
is_VBZ
target_NN
of_IN
autoreactive_JJ
T-cells_NNS
in_IN
IDDM_NN
._.

Target_NN
antigens_NNS
defined_VBN
by_IN
autoantibodies_NNS
in_IN
IDDM_NN
include_VBP
insulin_NN
,_,
a_DT
putative_JJ
glycolipid_NN
that_WDT
reacts_VBZ
with_IN
islet_NN
cell_NN
antibodies_NNS
,_,
and_CC
a_DT
64,000-M_CD
-LRB-_-LRB-
r_NN
-RRB-_-RRB-
protein_NN
recently_RB
identified_VBN
as_IN
glutamic_JJ
acid_NN
decarboxylase_NN
._.

In_IN
addition_NN
,_,
some_DT
IDDM_NN
sera_NN
that_WDT
contain_VBP
antibodies_NNS
to_TO
glutamic_JJ
acid_NN
decarboxylase_NN
also_RB
coprecipitate_VBP
a_DT
38,000-M_CD
-LRB-_-LRB-
r_NN
-RRB-_-RRB-
protein_NN
from_IN
islets_NNS
._.

This_DT
study_NN
used_VBD
a_DT
high_JJ
titer_NN
anti-38_NN
,000_CD
-_:
M_NN
-LRB-_-LRB-
r_NN
-RRB-_-RRB-
serum_NN
to_TO
screen_VB
bacteriophage_NN
lambda_NN
cDNA_NN
expression_NN
libraries_NNS
and_CC
identified_VBD
human_JJ
islet_NN
and_CC
placental_JJ
clones_NNS
encoding_VBG
jun-B_NN
,_,
the_DT
nuclear_JJ
transcription_NN
protein_NN
,_,
of_IN
predicted_VBN
38,000_CD
M_NN
-LRB-_-LRB-
r_NN
-RRB-_-RRB-
._.

Peripheral_JJ
blood_NN
T-cells_NNS
exhibited_VBD
significant_JJ
proliferation_NN
in_IN
response_NN
to_TO
a_DT
recombinant_JJ
fragment_NN
of_IN
jun-B_NN
-LRB-_-LRB-
amino_NN
acids_NNS
1-180_CD
-RRB-_-RRB-
in_IN
12_CD
of_IN
17_CD
-LRB-_-LRB-
71_CD
%_NN
-RRB-_-RRB-
recent-onset_JJ
IDDM_NN
subjects_NNS
,_,
8_CD
of_IN
16_CD
-LRB-_-LRB-
50_CD
%_NN
-RRB-_-RRB-
ICA-positive_JJ
first-degree_JJ
relatives_NNS
of_IN
IDDM_NN
subjects_NNS
who_WP
were_VBD
at_IN
risk_NN
,_,
3_CD
of_IN
12_CD
-LRB-_-LRB-
25_CD
%_NN
-RRB-_-RRB-
other_JJ
autoimmune_JJ
disease_NN
subjects_NNS
,_,
and_CC
0_CD
of_IN
10_CD
healthy_JJ
control_NN
subjects_NNS
._.

Proliferation_NN
to_TO
tetanus_NN
toxoid_NN
did_VBD
not_RB
differ_VB
significantly_RB
between_IN
the_DT
groups_NNS
._.

Responses_NNS
to_TO
jun-B_NN
were_VBD
not_RB
related_JJ
to_TO
age_NN
,_,
sex_NN
,_,
or_CC
human_JJ
leukocyte_NN
antigen_NN
status_NN
._.

Thus_RB
,_,
autoreactive_JJ
T-cells_NNS
identify_VBP
a_DT
novel_JJ
antigen_NN
,_,
p38_NN
jun-B_NN
,_,
in_IN
IDDM_NN
and_CC
appear_VBP
to_TO
indicate_VB
subjects_NNS
at_IN
risk_NN
for_IN
the_DT
development_NN
of_IN
clinical_JJ
disease_NN
._.

